CIML NK: Clinical Trials

1 trial of CIML NK, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow CIML NK: new trials by email Literature Review of CIML NK trials Research Report on CIML NK

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
CIML NK, Fludarabine, Cyclophosphamide - Acute Myeloid Leukemia, Myelodysplastic Syndromes
Phase 1RecruitingDana-Farber Cancer Institute502019-08-312026-06-17

Conditions studied

Leukemia (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Juvenile (1)  ·  Myelodysplastic Syndromes (1)  ·  Myeloproliferative Disorders (1)

Sponsors

Dana-Farber Cancer Institute (1)

Countries

United States (1)

Top investigators

Susanne Baumeister, MD (1)

Results publications

PMID 35349491